(Q34187622)

31 July 2017

Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL. (English)

1 reference

31 July 2017

1 reference

Kazuto Ito

1

1 reference

31 July 2017

Takumi Yamamoto

2

1 reference

31 July 2017

Masaru Ohi

3

1 reference

31 July 2017

Kohei Kurokawa

4

1 reference

31 July 2017

Kazuhiro Suzuki

5

1 reference

31 July 2017

Hidetoshi Yamanaka

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

31 July 2017

1 reference

31 July 2017

61

1 reference

31 July 2017

4

1 reference

31 July 2017

760-764

1 reference

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Systematic sextant biopsies in 651 patients referred for prostate evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902427-5

7 January 2021

10.1016/S0090-4295(02)02427-5

Identifiers

DOI

1 reference

release_pdba45pjzzbrzjtthvuulwia6y

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pdba45pjzzbrzjtthvuulwia6y

24 November 2022

mapped directly with Wikidata item

1 reference